Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Viemed Healthcare Inc VMD

Viemed Healthcare, Inc. through its subsidiaries, is a provider of home medical equipment (HME) and post-acute respiratory healthcare services in the United States. The Company’s service offerings are focused on effective in-home treatment with clinical practitioners providing therapy and counselling to patients in their homes using cutting edge technologies. The Company’s products and services include Home Medical Equipment, In-home sleep testing, and Healthcare staffing. Home Medical Equipment provides respiratory and other home medical equipment, including home ventilation, bi-level positive airway pressure (BiPAP) and continuous positive airway pressure (CPAP) devices, percussion vests, and other medical equipment. In-home sleep testing provides in home sleep apnea testing services. Healthcare staffing provides healthcare staffing and recruitment services. The Company provides home medical equipment services through its interest in East Alabama HomeMed, LLC (HomeMed).


NDAQ:VMD - Post by User

Comment by JackLamberton Nov 02, 2021 6:57pm
125 Views
Post# 34079765

RE:RE:RE:VMD trades 7 times its 2021 Adj. EBITDA

RE:RE:RE:VMD trades 7 times its 2021 Adj. EBITDA

It's striking there have been no insider buys.  I would imagine there is a tacit understanding by management that the optics of a buy would be very bad. 

And why buy now?  Wait three months and see what's going on with Covid.  Things were moving in June - then came delta   That central band of the US over to Colorado is where the cases are still growing    And still 1300 a day dead  yes dead      That's called a headwind   

Personally I don't care much about the phantom menace.  I am getting unhappy with the OIG thing though.  Throw them a couple million and a mea culpa and get it done.  Talk about Optics.  They can pay out OIG and long term debt and still have a years salary in the bank. 

<< Previous
Bullboard Posts
Next >>